AL
RDIV icon

Aspiriant LLC’s Invesco S&P Ultra Dividend Revenue ETF RDIV Stock Holding History

Aspiriant LLC’s Portfolio RDIV Stock Details RDIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$779K Hold
13,430
– – 0.02% 196
2026
Q1 		$748K Hold
13,430
– – 0.02% 181
2025
Q4 		$699K Hold
13,430
– – 0.02% 184
2025
Q3 		$700K Buy
+13,430
New +$676K 0.02% 177

Other funds holding RDIV

SLI
Sumitomo Life Insurance Tokyo, Japan $6.12B AUM 21.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.29B AUM 22.27% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Aspiriant LLC's RDIV Position: Q2 2026 in Review

Aspiriant LLC held its Invesco S&P Ultra Dividend Revenue ETF (RDIV) position steady in Q2 2026 at 13,430 shares worth $779K. The position accounts for 0.02% of the portfolio, ranked #196.

Aspiriant LLC first reported a position in RDIV in Q3 2025 and has held it in 4 quarters since. 127 funds tracked by Wall St. Rank hold RDIV as of Q2 2026.

  • Aspiriant LLC held 13,430 shares of Invesco S&P Ultra Dividend Revenue ETF worth $779K as of Q2 2026.
  • Aspiriant LLC left its Invesco S&P Ultra Dividend Revenue ETF share count unchanged in Q2 2026.
  • Invesco S&P Ultra Dividend Revenue ETF made up 0.02% of Aspiriant LLC's portfolio in Q2 2026, its #196 holding.
  • Aspiriant LLC first reported a position in Invesco S&P Ultra Dividend Revenue ETF in Q3 2025 and has held it in 4 quarters since.
  • 127 funds tracked by Wall St. Rank held Invesco S&P Ultra Dividend Revenue ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.